Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP)

OBJECTIVE: The Tysabri Observational Programme (TOP), which began >10 years ago, is an open-label, multinational, prospective observational study evaluating the long-term safety and effectiveness of natalizumab in relapsing-remitting multiple sclerosis patients. METHODS: These data provide a 10-y...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurol Neurosurg Psychiatry
Main Authors: Butzkueven, Helmut, Kappos, Ludwig, Wiendl, Heinz, Trojano, Maria, Spelman, Tim, Chang, Ih, Kasliwal, Rachna, Jaitly, Seema, Campbell, Nolan, Ho, Pei-Ran, Licata, Stephanie
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Multiple Sclerosis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7279201/
https://ncbi.nlm.nih.gov/pubmed/32234967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2019-322326
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados